From a study that analyzed brain images of more than 2,500 people with Parkinson's disease in 20 different countries, scientists were able to identify patterns of neurodegeneration and create metrics ...
Researchers at Karolinska Institutet have discovered new insights into brain changes in Parkinson's disease using advanced ...
The Oklahoma Medical Research Foundation has received a $3 million grant to study Parkinson's disease, potentially leading to ...
GOTHENBURG, SE / ACCESS Newswire / February 12, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, February 12, 2024 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company d ...
GOTHENBURG, SE / ACCESS Newswire / February 12, 2025 /IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, February ...
By creating a new metric, researchers envision the possibility of diagnostic and treatment advances for the disease, which is estimated to affect about 4 million people worldwide.
The U.S. Food and Drug Administration (FDA) has approved Onapgo (apomorphine hydrochloride) injection, the first and only ...
FDA Approves Supernus Pharmaceuticals’ Onapgo for Managing Motor Fluctuations in Parkinson Disease
Approval of Onapgo (apomorphine hydrochloride) marks the first and only subcutaneous apomorphine infusion device for managing ...
The Google cofounder has donated more than $1.5 billion to Parkinson’s research. Now, as he takes on autism, he’s also ...
Alumis Inc. will merge with a Southern California drug developer in a deal that extends the combined companies' cash into ...
Parkinson’s disease is a brain disorder that affects movement, making everyday tasks difficult for nearly one million people ...
GOTHENBURG, SE / ACCESS Newswire / February 7, 2025 /IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, February ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback